Elbasvir/grazoprevir - a new addition to the comedication list

Zepatier, a fixed dose combination product containing elbasvir and grazoprevir has been approved by the FDA for the treatment of hepatitis C infection.
Elbasvir/grazoprevir has been added to the antiviral class of comedications and is now available on the web and app versions of the interaction charts.